Free Trial

Vivos Therapeutics (VVOS) SEC Filings & 10K Form

Vivos Therapeutics logo
$4.98 +0.32 (+6.87%)
(As of 12/20/2024 05:45 PM ET)

Recent Vivos Therapeutics SEC Filings

DateFilerForm TypeView
12/20/2024
2:17 PM
V-CO Investors LLC (Filed by)
Vivos Therapeutics (Subject)
Form SCHEDULE 13G
11/27/2024
4:25 PM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:43 PM
Amman Bradford K. (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:47 PM
Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
1:59 PM
Ionic Ventures, LLC (Filed by)
Vivos Therapeutics (Subject)
Form SC 13G
09/20/2024
7:00 AM
Vivos Therapeutics (Filer)
Form 424B5
09/20/2024
7:05 AM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:00 AM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:00 PM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:24 PM
Vivos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
4:19 PM
Vivos Therapeutics (Filer)
Form 424B1
08/07/2024
11:15 PM
Vivos Therapeutics (Filer)
Form EFFECT
07/29/2024
8:06 PM
Vivos Therapeutics (Filer)
Form 10-K/A
07/30/2024
5:17 AM
Vivos Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/10/2024
7:00 AM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
7:53 PM
Amman Bradford K. (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
Lindsay Mark F. (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
Krammer Anja B (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
Green Ralph Elias (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
Thompson Matthew (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
SOKOLOW LEONARD J (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:53 PM
Huntsman Ronald Kirk (Reporting)
Vivos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:30 PM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
1:54 PM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:16 PM
Vivos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2024
11:15 PM
Vivos Therapeutics (Filer)
Form EFFECT
04/19/2024
6:52 PM
Vivos Therapeutics (Filer)
Form S-1/A
04/08/2024
7:22 PM
Vivos Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2024
7:38 PM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:55 AM
Vivos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
4:42 PM
Huntsman Ronald Kirk (Filed by)
Vivos Therapeutics (Subject)
Vivos Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VVOS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners